We are live on ! Find out more

60 hedge funds and large institutions have $3.67M invested in PAVmed in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more call options, than puts

Call options by funds: $39K | Put options by funds: $6K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

9% more funds holding

Funds holding: 5560 (+5)

0.01% more ownership

Funds ownership: 0.02%0.02% (+0.01%)

3% less capital invested

Capital invested by funds: $3.78M → $3.67M (-$113K)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

Holders
60
Holders Change
+5
Holders Change %
+9.09%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
12
Reduced
14
Closed
4
Calls
$39K
Puts
$6K
Net Calls
+$33K
Net Calls Change
-$7K

PAVM Hedge Fund Activity: Q3 2023 in Review

60 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2023, worth a combined $3.67M — down 3% from $3.78M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PAVM positions and 4 closed out — a net gain of 5 holders — while 12 added to existing stakes and 14 trimmed.

The largest buyer was Ayrton Capital, adding an estimated $618K. The largest seller was Bank of New York Mellon, cutting an estimated $23.4K.

  • 60 institutional investors held PAVmed (PAVM) as of Q3 2023, up from 55 in Q2 2023.
  • Funds reported $3.67M of PAVmed stock for Q3 2023, down 3% quarter-over-quarter.
  • 9 funds opened new PAVmed positions in Q3 2023 and 4 closed out, a net change of +5 holders.
  • The largest PAVmed buyer in Q3 2023 was Ayrton Capital, an estimated $618K added.
  • The largest PAVmed seller in Q3 2023 was Bank of New York Mellon, an estimated $23.4K sold.

Based on aggregated 13F filings for Q3 2023.